Dietmar Lohmann
- Ophthalmology top 0.2%
- Molecular Biology top 5%
- Oncology top 2%
- Genetics top 5%
- Cancer Research top 5%
- Co-authors
- Bernhard HorsthemkeMichael ZeschnigkNorbert BornfeldBrenda L. GallieEberhard PassargePetra TemmingClaudia H.D. MetzFrank Tschentscher
- Topics
- Ocular Oncology and Treatments (67 papers)Cancer-related Molecular Pathways (42 papers)Hedgehog Signaling Pathway Studies (14 papers)
- Cited by
- OphthalmologyOncologyCancer Research
- Partner nations
- GermanySwitzerlandCanada
In The Last Decade
Dietmar Lohmann
95 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Ophthalmology 2.1k
- Molecular Biology 1.9k
- Oncology 1.6k
- Genetics 640
- Cancer Research 442
Countries citing papers authored by Dietmar Lohmann
This map shows the geographic impact of Dietmar Lohmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dietmar Lohmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dietmar Lohmann more than expected).
Fields of papers citing papers by Dietmar Lohmann
This network shows the impact of papers produced by Dietmar Lohmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dietmar Lohmann. The network helps show where Dietmar Lohmann may publish in the future.
Co-authorship network of co-authors of Dietmar Lohmann
This figure shows the co-authorship network connecting the top 25 collaborators of Dietmar Lohmann. A scholar is included among the top collaborators of Dietmar Lohmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dietmar Lohmann. Dietmar Lohmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 14 | |
| 4 | 8 | |
| 5 | 133 | |
| 6 | 54 | |
| 7 | 15 | |
| 8 | 8 | |
| 9 | Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3breakdown → | 369 |
| 10 | 21 | |
| 11 | 243 | |
| 12 | 2 | |
| 13 | 21 | |
| 14 | 85 | |
| 15 | 89 | |
| 16 | 127 | |
| 17 | 6 | |
| 18 | 84 | |
| 19 | 11 | |
| 20 | 56 |
About Dietmar Lohmann
Dietmar Lohmann is a scholar working on Ophthalmology, Oncology and Genetics, having authored 98 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (67 papers), Cancer-related Molecular Pathways (42 papers) and Hedgehog Signaling Pathway Studies (14 papers). The work is most often cited by research in Ophthalmology (2.1k citations), Oncology (1.6k citations) and Cancer Research (442 citations). Dietmar Lohmann has collaborated with scholars based in Germany, Switzerland and Canada. Frequent co-authors include Bernhard Horsthemke, Michael Zeschnigk, Norbert Bornfeld, Brenda L. Gallie, Eberhard Passarge, Petra Temming, Claudia H.D. Metz, Frank Tschentscher, Ludger Klein‐Hitpaß and Gerasimos Anastassiou. Their work appears in journals such as Nucleic Acids Research, Nature Genetics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.